Published May 1, 2002 | Version v1
Journal article

An Internet-ready database for prospective randomized clinical trials of high-dose-rate brachytherapy for adenocarcinoma of the prostate

Description

Purpose: To demonstrate a new interactive Internet-ready database for prospective clinical trials in high-dose-rate (HDR) brachytherapy for prostate cancer. Methods and Materials: An Internet-ready database was created that allows common data acquisition and statistical analysis. Patient anonymity and confidentiality are preserved. These data forms include all common elements found from a survey of the databases. The forms allow the user to view patient data in a view-only or edit mode. Eight linked forms document patient data before and after receiving HDR therapy. The pretreatment forms are divided into four categories: staging, comorbid diseases, external beam radiotherapy data, and signs and symptoms. The posttreatment forms separate data by HDR implant information, HDR medications, posttreatment signs and symptoms, and follow-up data. The forms were tested for clinical usefulness. Conclusion: This Internet-based database enables the user to record and later analyze all relevant medical data and may become a reliable instrument for the follow-up of patients and evaluation of treatment results

Additional details

Identifiers

PII
S0360301602027037;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
53
Journal Issue
1
Journal Page Range
p. 104-115
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
34003730
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
DATA BASE MANAGEMENT; DOSE RATES; INTERNET; NEOPLASMS; PROSTATE; RESEARCH PROGRAMS
Descriptors DEC
BODY; COMPUTER NETWORKS; DISEASES; GLANDS; MALE GENITALS; MANAGEMENT; ORGANS

Optional Information

Copyright
Copyright (c) 2002 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.